mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0001 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |